» Articles » PMID: 33790780

The Eminent Role of MicroRNAs in the Pathogenesis of Alzheimer's Disease

Overview
Specialty Geriatrics
Date 2021 Apr 1
PMID 33790780
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is an irrevocable neurodegenerative condition characterized by the presence of senile plaques comprising amassed β-amyloid peptides (Aβ) and neurofibrillary tangles mainly comprising extremely phosphorylated Tau proteins. Recent studies have emphasized the role of microRNAs (miRNAs) in the development of AD. A number of miRNAs, namely, miR-200a-3p, miR-195, miR-338-5p, miR-34a-5p, miR-125b-5p, miR-132, miR-384, miR-339-5p, miR-135b, miR-425-5p, and miR-339-5p, have been shown to participate in the development of AD through interacting with BACE1. Other miRNAs might affect the inflammatory responses in the course of AD. Aberrant expression of several miRNAs in the plasma samples of AD subjects has been shown to have the aptitude for differentiation of AD subjects from healthy subjects. Finally, a number of AD-modifying agents affect miRNA profile in cell cultures or animal models. We have performed a comprehensive search and summarized the obtained data about the function of miRNAs in AD in the current review article.

Citing Articles

Application of the Trend of miRNA Expression Levels in APP/PS1 Mice Plasma for the Early Diagnosis of Alzheimer's Disease.

Zhang Y, Wang Y, Zhao F Mol Neurobiol. 2025; .

PMID: 39937416 DOI: 10.1007/s12035-025-04743-6.


Identifying Hub Genes and miRNAs Associated with Alzheimer's Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies.

Gascon E, Calvo A, Molina N, Zaragoza P, Osta R Biomolecules. 2025; 14(12.

PMID: 39766348 PMC: 11726968. DOI: 10.3390/biom14121641.


A review on gut microbiota and miRNA crosstalk: implications for Alzheimer's disease.

Ayyanar M, Vijayan M Geroscience. 2024; 47(1):339-385.

PMID: 39562408 PMC: 11872870. DOI: 10.1007/s11357-024-01432-5.


Exosomal MicroRNAs modulate the cognitive function in fasudil treated APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer's disease.

Yan Y, Gao Y, Kumar G, Fang Q, Yan H, Zhang N Metab Brain Dis. 2024; 39(7):1335-1351.

PMID: 39088109 PMC: 11513711. DOI: 10.1007/s11011-024-01395-8.


Epigenetic Mechanisms of Aluminum-Induced Neurotoxicity and Alzheimer's Disease: A Focus on Non-Coding RNAs.

Aschner M, Skalny A, Santamaria A, Rocha J, Mansouri B, Tizabi Y Neurochem Res. 2024; 49(11):2988-3005.

PMID: 39060769 DOI: 10.1007/s11064-024-04214-9.


References
1.
El Fatimy R, Li S, Chen Z, Mushannen T, Gongala S, Wei Z . MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways. Acta Neuropathol. 2018; 136(4):537-555. PMC: 6132948. DOI: 10.1007/s00401-018-1880-5. View

2.
Han C, Guo L, Yang Y, Guan Q, Shen H, Sheng Y . Mechanism of microRNA-22 in regulating neuroinflammation in Alzheimer's disease. Brain Behav. 2020; 10(6):e01627. PMC: 7303389. DOI: 10.1002/brb3.1627. View

3.
Liu C, Wang J, Li L, Wang P . MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease. Int J Mol Med. 2014; 34(1):160-6. DOI: 10.3892/ijmm.2014.1780. View

4.
Zhang S, Huang S, Gao S, Wang Y, Jin P, Lu F . Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR‑613. Mol Med Rep. 2019; 20(4):3849-3857. PMC: 6755198. DOI: 10.3892/mmr.2019.10634. View

5.
Xu N, Li A, Ji L, Ye Y, Wang Z, Tong L . miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q. Eur J Histochem. 2019; 63(2). PMC: 6511887. DOI: 10.4081/ejh.2019.3008. View